银丹心脑通胶囊治疗糖尿病合并高脂血症的疗效观察 彭景拾 【期刊名称】《糖尿病新世界》 【年(卷),期】2015(035)022 【摘 要】Objective To comparatively analyze the clinical effect of Yindanxinnaotong capsule in the treatment of patients with diabetes mellitus and hyperlipidemia. Methods A total of 310 patients with type 2 diabetes mellitus complicated with hyperlipidemia admitted in our hospital from June 2012 to June 2014 these three years were selected as the subjects and di-vided into observation group and control group, 155 cases in each group according to the random number table method. Both groups were given diabetic diet guidance after admission, Metformin for controlling blood glucose level, and insulin therapy was given to those with poor control of blood glucose level by Metformin based on the patients′ conditions. In addi-tion, the observation group were treated by Yindanxinnaotong capsule. After 8 weeks of treatment, the blood glucose levels [fasting plasma glucose(FPG), postprandial 2h plasma glucose(P2hPG), glycosylated hemoglobin(HbA1c)] and blood lipid lev-els[total cholesterol(TC), total triglyceride (TG), low density lipoprotein cholesterol(LDL-C), high density lipoprotein choles-terol(HDL-C)] and the clinical treatment efficiency were compared and analyzed between the two groups. Results After 8 weeks of treatment, the indicators of blood glucose and blood lipid levels improved in both groups compared with those be-fore treatment, moreover, the improvement was more significant in the observation group (P<0.05). The total effective rate in the observation group was significantly higher than that in the control group with statistically significant difference (P<0.05). Conclusion Yindanxinnaotong capsule is a kind of Chinese medicine, which can significantly control the blood glucose lev-el fluctuation and reduce the blood lipid level. For diabetic patients with hyperlipidemia, Yindanxinnaotong capsule com-bined with the conventional treatment is conducive to improving the clinical symptoms so it is worth wide application.%目的 对比分析银丹心脑通胶囊对糖尿病合并高脂血症患者治疗的临床效果. 方法 选择该院于2012年6月—2014年6月3年期间收治的2型糖尿病合并高脂血症患者共310例为研究对象,采用随机数字法将入组的310例患者随机分为观察组和对照组,每组各155例.对照组患者在入院后现进行糖尿病饮食指导,给予饮食控制后再对两组患者使用二甲双胍控制血糖水平,控制情况不佳者依据个体情况加用胰岛素治疗. 观察组在对照组的治疗基础上加用银丹心脑通胶囊治疗,两组均连续治疗8w后对比分析两组糖尿病合并高脂血症患者的血糖水平包括:空腹血糖(FPG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA1c);血脂水平包括:总胆固醇(TC)、总甘油三酯(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)以及临床治疗有效率. 结果 两组患者在治疗8 w后较治疗前相比,血糖各项指标和血脂各项指标均有所改善,观察组改善程度明显优于对照组(P<0.05);治疗总有效率方面观察组显著优于对照组差异有统计学意义(P<0.05). 结论 银丹心脑通胶囊为中药制剂,在控制血糖波动、降低血脂水平方面作用显著,对于糖尿病合并高脂血症的患者来说,在常规治疗基础上加用银丹心脑通胶囊更利于改善临床症状,值得广泛推广应用. 【总页数】3页(P68-70) 【作 者】彭景拾 【作者单位】光山县人民医院内科,河南信阳 465450 【正文语种】中 文 【中图分类】R59 【相关文献】 1.银丹心脑通胶囊治疗糖尿病合并高脂血症医治方案和治疗效果 [J], 张丹; 2.探析银丹心脑通胶囊治疗糖尿病合并高脂血症的有效性 [J], 孙克苏 3.浅析银丹心脑通胶囊治疗糖尿病合并高脂血症的安全性观察 [J], 张傅侯 4.银丹心脑通胶囊治疗糖尿病合并高脂血症患者的临床疗效观察 [J], 辛向前 5.银丹心脑通胶囊治疗糖尿病合并高脂血症80例临床疗效分析 [J], 韩俊 因版权原因，仅展示原文概要，查看原文内容请购买 本文来源：https://www.wddqw.com/doc/853043810608763231126edb6f1aff00bed57087.html